Masimo announced today that the RDrainbow LiteSET sensor has received the CE mark and is available for sale. The sensor enables monitoring of the Masimo oxygen reserve index (ORi) and RPVi, which is an improved PVi that allows clinicians to continuously assess humoral responses in a non-invasive manner. Sex 1, the cost is only a fraction of the traumatic method and the rainbow sensor. The rainbowLite sensor uses twice as many light wavelengths as the SET sensor, allowing the rainbowLite sensor to be used with the MasimoSETTM motion and Measure-through Motion and Low Perfusion pulse oximeter to provide ORi and RPVi. Ori is the first non-invasive, continuous parameter that provides insight into the oxygen reserve of patients in the moderate hyperoxia range. When used in conjunction with the SET pulse oximeter, ORi can provide an upcoming deoxygen saturation warning for clinicians to intervene faster. For example, in one study, 25 children underwent general anesthesia with orotracheal intubation. The researchers found that ORi can help clinicians recognize 31.5 seconds before the apparent change in oxygen saturation (SpO2) occurs. Outcoming deoxygenation 2 . In another recent study, 106 adult patients underwent elective arterial catheterization and blood gas analysis during the procedure. The investigators found a significant association between changes in PaO2 and changes in ORi3. In addition, for patients receiving supplemental oxygen, ORi can gain insights into oxygen reserves while increasing oxygen supply. Masimo founder and CEO Joe Kiani said: “With the rainbowLite sensor, clinicians who rely on the powerful SET pulse oximeter technology can add ORi and the newly launched RPVi in patient monitoring. What we are excited about is that The listed markets have responded positively to ORi, and clinicians have feedback that huge profits have been found in the profits of ORi monitoring. Therefore, we provide ORi and RPVi through a cost-effective solution. The representative of this program is RDrainbowLiteSET. Hospitals with RDrainbowLiteSET as standard are paying only slightly more for each sensor than SET." MasimoRPVi is a multi-wavelength version of the pulse perfusion variation index (PVi). RPVi aims to provide an updated version of fluid volume changes assessment based on PVi. More than 90 independent clinical studies have shown that PVi is equivalent to all types of invasive monitoring methods6. With the addition of RDrainbowLiteSET, the RD sensor family now has 3 levels of functionality to choose from: RDSET with 2 wavelengths (2 LEDs) and equipped with the SET O pulse oximeter; 4 wavelengths (4 LEDs) RDrainbowLiteSET loaded with ORi and RPVi measurement functions; RDrainbowSET with 7 wavelengths (7 or more LEDs) and capable of measuring other advanced non-invasive parameters including SpHb (total hemoglobin), SpCO (carbon hemoglobin), SpMet (methemoglobin) ) and SpOC (oxygen content). Like RDSET sensors, RDrainbowLiteSET sensors are designed to maximize patient comfort and optimize the workflow of clinicians. These sensors are lightweight and have a flat, soft, smooth-edged cable that can be placed comfortably on the patient's hands and feet. These sensors are equipped with an intuitive sensor-to-cable connection that is connected in place by tactile and audible feedback, with patterns printed on both sides to assist the application. ORi and RPVi measuring devices and RDrainbow LiteSET sensors have not been approved by FDA 510(k) and are not listed in the United States.